Cargando…

Population-based human immunodeficiency virus 1 drug resistance profiles among individuals who experienced virological failure to first-line antiretroviral therapy in Henan, China during 2010–2011

BACKGROUND: In Henan, China, first-line antiretroviral treatment (ART) was implemented early in a large number of treatment-experienced patients who were more likely to have a drug resistance. Therefore, we investigated the human immunodeficiency virus (HIV)-1 drug resistance profiles among patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jia, Wu, Yasong, Yang, Wenjie, Xue, Xiujuan, Sun, Guoqing, Liu, Chunhua, Tian, Suian, Sun, Dingyong, Zhu, Qian, Wang, Zhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483220/ https://www.ncbi.nlm.nih.gov/pubmed/26120348 http://dx.doi.org/10.1186/s12981-015-0062-y

Ejemplares similares

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Causes of Death among AIDS Patients after Introduction of Free Combination Antiretroviral Therapy (cART) in Three Chinese Provinces, 2010–2011
por: Wang, Liyan, et al.
Publicado: (2015)

Rabies in Henan Province, China, 2010–2012
por: Li, Guo-Wei, et al.
Publicado: (2014)

HIV drug resistance and antiretroviral therapy programs in Henan, China
por: Liu, Zhi-Bin, et al.
Publicado: (2020)

Pyrazinamide Resistance and Mutation Patterns Among Multidrug-Resistant Mycobacterium tuberculosis from Henan Province
por: Shi, Jie, et al.
Publicado: (2020)

Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005–2012
por: Chen, Fangfang, et al.
Publicado: (2015)

2487. Low Rate of Virologic Failure in Antiretroviral Experienced Patients Prescribed Once Daily Raltegravir
por: Hsu, Ricky, et al.
Publicado: (2019)

Correction: Spatiotemporal Scan and Age-Period-Cohort Analysis of Hepatitis C Virus in Henan, China: 2005-2012
por: Chen, Fangfang, et al.
Publicado: (2015)

Changes in the Incidence of Congenital Anomalies in Henan Province, China, from 1997 to 2011
por: Xia, Lei, et al.
Publicado: (2015)

978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV
por: Mounzer, Karam, et al.
Publicado: (2019)

Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d’Ivoire West Africa
por: Tchounga, Boris K., et al.
Publicado: (2020)

The cancer incidence and mortality among children and adolescents during the period of 2010‐2014 in Henan Province, China
por: Chen, Qiong, et al.
Publicado: (2019)

Fitness Cost of Antiretroviral Drug Resistance Mutations on the pol Gene during Analytical Antiretroviral Treatment Interruption among Individuals Experiencing Virological Failure
por: Hunter, James R., et al.
Publicado: (2021)

2502. Impact of Pharmacist-Led Antiretroviral Therapy Simplification Initiative in Heavily Treatment-Experienced Patients on Virologic Control
por: Jimenez, Humberto R, et al.
Publicado: (2019)

Nationwide Cohort Study of Antiretroviral Therapy Timing: Treatment Dropout and Virological Failure in China, 2011–2015
por: Zhao, Yan, et al.
Publicado: (2019)

Genetic Diversity and Acquired Drug Resistance Mutations Detected by Deep Sequencing in Virologic Failures among Antiretroviral Treatment Experienced Human Immunodeficiency Virus-1 Patients in a Pastoralist Region of Ethiopia
por: Tachbele, Erdaw, et al.
Publicado: (2021)

HIV drug resistance and antiretroviral therapy programs in Henan, China-authors’ reply
por: Zuo, Lulu, et al.
Publicado: (2020)

Assessment of the Hepatitis C Surveillance System in Henan, China: 2014~2016
por: Li, Jie, et al.
Publicado: (2018)

Immunological factors associated with discordant virological response postcombination antiretroviral therapy in pediatric human immunodeficiency virus infection
por: Singh, Ravinder, et al.
Publicado: (2022)

Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2023)

Epidemiological and Etiological Characteristics of Fever, Thrombocytopenia and Leukopenia Syndrome in Henan Province, China, 2011–2012
por: Huang, Xueyong, et al.
Publicado: (2014)

Genetic Diversity and Acquired Drug Resistance Mutations Detected by Deep Sequencing in Virologic Failures Among Antiretroviral Treatment Experienced Human Immunodeficiency Virus-1 Patients in a Pastoralist Region of Ethiopia [Corrigendum]
Publicado: (2021)

Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients
por: Patel, Dishank, et al.
Publicado: (2013)

A study of antiretroviral resistance patterns in treatment experienced and naive human immunodeficiency virus infected-patients
por: Harjani, Raj, et al.
Publicado: (2016)

Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015
por: Liu, Pengtao, et al.
Publicado: (2018)

Virologic outcomes of people living with human immunodeficiency virus who started antiretroviral treatment on the same-day of diagnosis in Ethiopia: A multicenter observational study
por: Ahmed, Ismael, et al.
Publicado: (2021)

Molecular transmission network of pretreatment drug resistance among human immunodeficiency virus-positive individuals and the impact of virological failure on those who received antiretroviral therapy in China
por: Chen, Hongli, et al.
Publicado: (2022)

Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers
por: Chen, Wanyi, et al.
Publicado: (2023)

Two‐drug antiretroviral regimens: an assessment of virologic response and durability among treatment‐experienced persons living with HIV in the OPERA(®) Observational Database
por: Pierone, Gerald, et al.
Publicado: (2019)

Antiretroviral Drug-Resistance Mutations on the Gag Gene: Mutation Dynamics during Analytic Treatment Interruption among Individuals Experiencing Virologic Failure
por: Hunter, James R., et al.
Publicado: (2022)

Attrition among Human Immunodeficiency Virus (HIV)- Infected Patients Initiating Antiretroviral Therapy in China, 2003–2010
por: Zhu, Hao, et al.
Publicado: (2012)

Cancer incidence and mortality in Henan province, 2012
por: Liu, Shuzheng, et al.
Publicado: (2016)

Prevalence of transmitted drug resistance mutations among patients infected with human immunodeficiency virus type 1 (HIV-1) in Henan Province, China
por: Liu, Jinjin, et al.
Publicado: (2022)

Different Distribution of HIV-1 Subtype and Drug Resistance Were Found among Treatment Naïve Individuals in Henan, Guangxi, and Yunnan Province of China
por: Li, Lin, et al.
Publicado: (2013)

HIV-1 subtype diversity, drug resistance, and genetic transmission networks in men who have sex with men with virologic failure in antiretroviral therapy in Sichuan, China, 2011 to 2017
por: Yuan, Dan, et al.
Publicado: (2019)

Time-trend of the incidence and mortality of esophageal cancer from 2010 to 2018 and its statistics in 2018 in Henan, China
por: Zhang, Jian-Gong, et al.
Publicado: (2022)

Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012
por: Wang, Jing, et al.
Publicado: (2014)

Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
por: Abdissa, Alemseged, et al.
Publicado: (2014)

Pregnancy and Virologic Response to Antiretroviral Therapy in South Africa
por: Westreich, Daniel, et al.
Publicado: (2011)

The management of treatment-experienced HIV patients (including virologic failure and switches)
por: Cutrell, James, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_intl9700i5dacp4u7ghtetf5up